These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 25051722)
1. [The hepatoprotective activity of remaxol and S-adenosyl-L-methionine for liver damage caused by reserve-series antituberculosis drugs]. Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Vasil'eva SN; Vitovskaia ML Arkh Patol; 2013; 75(2):25-9. PubMed ID: 24006761 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacological activity of runihol and S-adenosyl-L-methionine in rats with experimental liver damage by reserve antituberculosis drugs]. Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Okovityĭ SV; Vasil'eva SN; Vitovskaia ML Eksp Klin Farmakol; 2013; 76(9):27-31. PubMed ID: 24432566 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study of hepatoprotective action of remaxol, reamberin and ademethionine in liver injury induced by antituberculosis drugs (experimental study)]. Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Kovalenko AL; Vasil'eva SN; Romantsov MG Antibiot Khimioter; 2011; 56(1-2):13-7. PubMed ID: 21780666 [TBL] [Abstract][Full Text] [Related]
4. [Hepato- and endothelioprotective action of runihol and ademetionine in experimental liver injury induced by TB drugs in combination with alcohol]. Sukhanov DS; Artyushkova EB; Dudka VT Patol Fiziol Eksp Ter; 2013; (2):45-9. PubMed ID: 24000714 [TBL] [Abstract][Full Text] [Related]
5. [The effect of runihol and exogenous S-adenosyl-L-methionine on the morphological pattern of the liver upon hepatotoxic exposure to reserve-series antituberculous drugs]. Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Vasil'eva SN; Vitovskaia ML Arkh Patol; 2012; 74(5):51-4, 56. PubMed ID: 23342661 [TBL] [Abstract][Full Text] [Related]
6. [The hepatotropic activity of runihol and ademethionine against experimental liver damage caused by first-line antituberculosis drugs]. Sukhanov DS; Vinogradova TI; Zabolotnykh NV; Vitovskaia ML; Kovalenko AL Arkh Patol; 2014; 76(2):26-30. PubMed ID: 25051722 [TBL] [Abstract][Full Text] [Related]
8. [The pharmacological therapy of intrahepatic cholestasis]. Coltorti M Ann Ital Med Int; 1993 Oct; 8 Suppl():41S-47S. PubMed ID: 8117520 [TBL] [Abstract][Full Text] [Related]
9. [Drug-induced liver damage and the problem of its pharmacological correction]. Somova MN; Muzalevskaia EN; Nikolaevskiĭ VA; Buzlama AV; Batishcheva GA; Chernov IuN Eksp Klin Farmakol; 2013; 76(9):38-43. PubMed ID: 24432568 [TBL] [Abstract][Full Text] [Related]
10. Antituberculosis drugs and hepatotoxicity. Yew WW; Leung CC Respirology; 2006 Nov; 11(6):699-707. PubMed ID: 17052297 [TBL] [Abstract][Full Text] [Related]
11. [Ademetionine: the state of the art and future prospects]. Almasio P; Pagliaro L Ann Ital Med Int; 1993 Oct; 8 Suppl():52S-55S. PubMed ID: 8117523 [TBL] [Abstract][Full Text] [Related]
12. The use of SAMe in chemotherapy-induced liver injury. Vincenzi B; Russo A; Terenzio A; Galvano A; Santini D; Vorini F; Antonelli-Incalzi R; Vespasiani-Gentilucci U; Tonini G Crit Rev Oncol Hematol; 2018 Oct; 130():70-77. PubMed ID: 30196914 [TBL] [Abstract][Full Text] [Related]